Autolus Therapeutics plc (AUTL)

NASDAQ: AUTL · Real-Time Price · USD

1.490

+0.020 (1.36%)

At close: Apr 10, 2026, 4:00 PM EDT

1.520

+0.030 (2.01%)

After-hours: Apr 10, 2026, 7:32 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Sep '18 Sep 30, 2018	Sep '17 Sep 30, 2017
Developing and Commercializing CAR-T Therapies	75.39M	10.12M	1.70M	6.36M	2.33M
Developing and Commercializing CAR-T Therapies Growth	644.94%	496.00%	-73.30%	172.96%	35.86%
Total	75.39M	10.12M	1.70M	6.36M	2.33M
Total Growth	644.94%	496.00%	-73.30%	172.96%	35.86%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Sep '18 Sep 30, 2018	Sep '17 Sep 30, 2017
United States of America	75.34M	-	1.35M	6.19M	1.51M
United States of America Growth	-	-	-78.17%	311.02%	-
Europe	50.00K	10.12M	-	-	-
Europe Growth	-99.51%	-	-	-	-
United Kingdom	-	-	346.00K	-	-
Total	75.39M	10.12M	1.70M	6.19M	1.51M
Total Growth	644.94%	496.00%	-72.59%	311.02%	522.73%

Source: S&P Global Market Intelligence.